Departamento de Cirurxía e Especialidades Médico-Cirúrxicas
Departamento
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (29)
2024
-
Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: Focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration
Pharmacological Research, Vol. 205
-
Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers
Journal of Translational Medicine, Vol. 22, Núm. 1
-
Edoxaban treatment in a post-infarction experimental model
European Journal of Pharmacology, Vol. 962
-
Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation
Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23
-
Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness
Revista Espanola de Cardiologia, Vol. 77, Núm. 2, pp. 150-157
2023
-
Clinical Profiling and Biomarkers for Post-Operative Atrial Fibrillation Prediction in Patients Undergoing Cardiac Surgery
Journal of Clinical Medicine, Vol. 12, Núm. 10
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
RSPO4 is a potential risk gene of stages III–IV, grade C periodontitis through effects on innate immune response and oral barrier integrity
Journal of Clinical Periodontology, Vol. 50, Núm. 4, pp. 476-486
-
Single-cell immune profiling of Meniere Disease patients
Clinical Immunology, Vol. 252
2022
-
Methods for the Detection of Circulating Biomarkers in Cancer Patients
Advances in experimental medicine and biology, Vol. 1379, pp. 525-552
-
Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin
Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 16, pp. 4416-4427
2021
-
Correction to: Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS (Intensive Care Medicine, (2020), 46, 12, (2200-2211), 10.1007/s00134-020-06192-2)
Intensive Care Medicine
-
Letter to the editor: “Liquid biopsy based on saliva cell-free DNA as a potential biomarker for head and neck cancer”
Oral Oncology
-
Saliva gene promoter hypermethylation as a biomarker in oral cancer
Journal of Clinical Medicine, Vol. 10, Núm. 9
-
Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part i: A diagnostic accuracy meta-analysis
Journal of Personalized Medicine, Vol. 11, Núm. 6
-
Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part ii: A cancer risk meta-analysis
Journal of Personalized Medicine, Vol. 11, Núm. 7
2020
-
Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: A meta-analysis
Journal of Clinical Medicine, Vol. 9, Núm. 5
-
Global gene expression characterization of circulating tumor cells in metastasic castration-resistant prostate cancer patients
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-14
-
Prognostic factors that modify outcomes of vestibular rehabilitation in elderly patients with falls
Aging Clinical and Experimental Research, Vol. 32, Núm. 2, pp. 223-228
-
Response to commentary by Lu and Wang on “Salivary biomarkers for cancer diagnosis: a meta-analysis”
Annals of Medicine